Mapping the antigenic and genetic evolution of influenza virus

Science

Volumn 305, Issue 5682, 2004, Pages 371-376

  Smith, Derek J ^a,b   Lapedes, Alan S ^c   De Jong, Jan C ^b   Bestebroer, Theo M ^b   Rimmelzwaan, Guus F ^b   Osterhaus, Albert D M E ^b   Fouchier, Ron A M ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; VACCINES;

ANTIGENIC EVOLUTION; GENETIC EVOLUTIONS;

VIRUSES;

VACCINE;

INFLUENZA; MEDICINE;

AMINO ACID SUBSTITUTION; ANTIGENICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE MAPPING; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MOLECULAR EVOLUTION; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; QUANTITATIVE GENETICS; VIRUS GENE; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; EVOLUTION, MOLECULAR; GENES, VIRAL; GENETIC DRIFT; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; SEASONS; VARIATION (GENETICS); VIROLOGY;

INFLUENZA A VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS B; RNA VIRUSES;

EID: 3142682239     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1097211     Document Type: Article

References (38)

1. G. K. Hirst, J. Exp. Med. 78, 407 (1943).
2. D. D. Richman, T. Wrin, S. J. Little, C. J. Petropoulos, Proc. Natl. Acad. Sci. U.S.A. 100, 4144 (2003).
3. D. H. O'Connor et al., Nature Med. 8, 493 (2002).
4. A. Lapedes, R. Farber, J. Theor. Biol. 212, 57 (2001).
5. K. Stohr, Lancet Infect. Dis. 2, 517 (2002).
6. A. W. Hampson, in Influenza, C. W. Potter, Ed. (Elsevier, London, 2002), pp. 49-85.
7. J. E. Salk, P. C. Suriano, Am. J. Public Health 39, 345 (1949).
8. E. D. Kilbourne et al., Proc. Natl. Acad. Sci. U.S.A. 99, 10748 (2002).
9. Materials and methods are available as supporting material on Science Online. For software, see www. antigenic-cartography.org.
10. R. M. Bush, W. M. Fitch, C. A. Bender, N. J. Cox, Mol. Biol. Evol. 16, 1457 (1999).
11. R. M. Bush, C. A. Bender, K. Subbarao, N. J. Cox, W. M. Fitch, Science 286, 1921 (1999).
12. J. B. Plotkin, J. Dushoff, S. A. Levin, Proc. Natl. Acad. Sci. U.S.A. 99, 6263 (2002).
13. N. M. Ferguson, A. P. Galvani, R. M. Bush, Nature 422, 428 (2003).
14. P. H. A. Sneath, R. R. Sokal, Numerical Taxonomy (Freeman, San Francisco, 1973).
15. T. F. Weijers et al. J. Virol. Methods 10, 241 (1985).
16. D. J. Alexander et al., Avian Pathol. 26, 399 (1997).
17. P. A. Underwood J. Gen. Virol. 62 (Pt. 1), 153 (1982).
18. A. Dekker, G. Wensvoort, C. Terpstra, Vet. Microbiol. 47, 317 (1995).
19. J. M. Daly et al., J. Gen. Virol. 77 (Pt. 4), 661 (1996).
20. A. S. Perelson, G. F. Oster, J. Theor. Biol. 81, 645 (1979).
21. L. Edelstein, R. Rosen, J. Theor. Biol. 73, 181 (1978).
22. D. J. Smith, S. Forrest, A. S. Perelson, in Artificial Immune Systems and Their Applications, D, Dasgupta, Ed. (Springer Verlag, Berlin, 1998), pp. 105-114.
23. D. J. Smith, S. Forrest, D. H. Ackley, A. S. Perelson, Proc. Natl. Acad. Sci. U.S.A. 96, 14001 (1999).
24. J. Kruskal, Psychometrika 29, 115 (1964).
25. R. Shepherd, Hum. Factors 5, 33 (1963).
26. Newly sequenced HA1 domain accession numbers: AY660991-AY661211. previously published HA1 domain accession numbers are in the supporting material.
27. C. A. Macken, H. Lu, J. Goodman, L. Boykin, in Options for the Control of Influenza IV, A. D. M. E. Osterhaus, N. Cox, A. W. Hampson, Eds. (Elsevier Science B.V., Amsterdam, 2001), pp. 103-106.
28. D. C. Wiley, I. A. Wilson, J. J. Skehel., Nature 289, 373 (1981).
29. I. A. Wilson, J. J. Skehel, D. C. Wiley, Nature 289, 366 (1981).
30. G. W. Both, M. J. Sleigh, N. J. Cox, A. P. Kendal, J. Virol. 48, 52 (1983).
31. A. J. Hay, V. Gregory, A. R. Douglas, Y. P. Lin, Philos. Trans. R. Soc. London B. Biol. Sci. 356, 1861 (2001).
32. Single-letter abbreviations for the amino acid residues are as follows: I, Ile; K, Lys; N, Asn; and S, Ser.
33. J. R. Gog, B. T. Grenfell, Proc. Natl. Acad. Sci. U.S.A. 99, 17209 (2002).
34. J. R. Gog, G. F. Rimmelzwaan, A. D. Osterhaus, B. T. Grenfell, Proc. Natl. Acad. Sci. U.S.A. 100, 11143 (2003).
35. B. T. Grenfell et al., Science 303, 327 (2004).
36. D. A. Lennette, in Diagnostic Procedures for Viral, Ricketssial and Chlamydial Infections, E. H. Lennette, D. A. Lennette, E. T. Lennette, Eds. (American Public Health Association, Washington, DC, 1995).
37. B. Korber et al., Science 288, 1789 (2000).
38. We thank R. van Beek, W. Beyer, T. Bhattacharya, R. Bush, N. Cox, B. Grenfell, J. Gog, H. Gutowitz, A. Hay, R. Hightower, T. Jones, A. Tang, the contributors to the WHO global influenza surveillance network, and the maintainers of the influenza Sequence Database (www.flu.tant.gov). We acknowledge the support of the Santa Fe Institute and the Dutch National Institute of Public Health and the Environment (RIVM). D.J.S. was supported by European Union grant QLRT-2001-01034. A.S.L. was supported by the U.S. Department of Energy, contract W-7405-ENG-36, under the Laboratory-Directed Research and Development program. R.A.M.F. is a fellow of the Royal Dutch Academy of Arts and Sciences.